Methods 58 cases of chronic fulminant hepatitis patients were randomly divided into the treatment group (n=29) and the control group (n=29) to receive Prostaglandin E1 for three weeks.
Methods 58 cases of chronic fulminant hepatitis patients were randomly divided into the treatment group (n=29) and the control group (n=29) to receive Prostaglandin E1 for three weeks.
方法将58例慢性重型肝炎患者随机、平均分为脂微球载体前列腺素治疗组与对照组，疗程3周。